// App-Quantinova.ai

1209 : Phospholipase A2 Group 5 Is a Potential Therapeutic Target for Osteoarthritis Treatment

Researchers

Presenter

  • Ming Liu

Principal Investigators

  • Andrew Furey

  • Weidong Zhang

  • Sergei Likhodi

  • Edward Randell

  • Proton Rahman

Medical Centers

  • Guangju Zhai

  • Discipline of Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada

  • Memorial University of Newfoundland, St. John's, NF, Canada

  • Jilin University, Changchun, China

  • Rheumatology, St. Clar-s Mercy Hospital, St. John's, NF, Canada

Locations

  • Canada

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Phospholipase A2, membrane associated

  • Interleukin 1 beta

  • Interleukin 6

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved